USPTO serial 90559674
MIRAVO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- STOIDES, KATHERINE
- Law office
- TMEG LAW OFFICE 101 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with MIRAVO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Mississauga, Ontario, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gary P. Oakeson
Gary P. Oakeson THORPE NORTH & WESTERN8180 S. 700 E., SUITE 350SANDY, UT 84070UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Operation of a commercial health care business, namely, developing marketing strategies all in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; operation of a commercial health care business, namely, developing of marketing strategies all in the field of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of pharmaceuticals and drugs, namely, developing marketing strategies all in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of health care products, namely, developing marketing strategies all in the field of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; Operation of a commercial health care business, namely, distributorship services in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; operation of a commercial health care business, namely, distributorship services in the field of non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of pharmaceuticals and drugs, namely, distributorship services in the field of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; commercialization of health care products, namely, distributorship services in the field of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations | ACTIVE | — |
| 040 | Custom manufacturing of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; custom manufacturing of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations | ACTIVE | — |
| 042 | Research, development and design of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; research, development and design of health care products, namely, non-medicated and non-prescription preparations used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations | ACTIVE | — |
| 045 | Licensing of pharmaceuticals and drugs used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations; Licensing of health care products, namely, non-medicated and non-prescription products used to improve, treat and prevent diseases, disorders, conditions, ailments, and infestations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nuvo Pharmaceuticals Inc.
- Other trademarks in Class 035
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named MIRAVO
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 30, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Apr 30, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jan 6, 2024 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 6, 2024 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 6, 2024 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 14, 2023 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Mar 24, 2023 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 24, 2023 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 24, 2023 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 6, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 6, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 3, 2023 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Dec 7, 2022 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Dec 7, 2022 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Dec 7, 2022 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| May 27, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| May 27, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| May 27, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 3, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 3, 2022 | ALIE | ASSIGNED TO LIE | — |
| May 3, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 3, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 3, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 4, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 29, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 28, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 28, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 3, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 8, 2021 | NWAP | NEW APPLICATION ENTERED | — |